DE3781605T2 - Geraet zum ueberwachen von glukose. - Google Patents
Geraet zum ueberwachen von glukose.Info
- Publication number
- DE3781605T2 DE3781605T2 DE8787304539T DE3781605T DE3781605T2 DE 3781605 T2 DE3781605 T2 DE 3781605T2 DE 8787304539 T DE8787304539 T DE 8787304539T DE 3781605 T DE3781605 T DE 3781605T DE 3781605 T2 DE3781605 T2 DE 3781605T2
- Authority
- DE
- Germany
- Prior art keywords
- dye
- glucose
- conjugate
- light
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims description 77
- 239000008103 glucose Substances 0.000 title claims description 77
- 238000012544 monitoring process Methods 0.000 title claims description 8
- 239000000975 dye Substances 0.000 claims description 77
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 29
- 239000001301 oxygen Substances 0.000 claims description 29
- 229910052760 oxygen Inorganic materials 0.000 claims description 29
- 239000013307 optical fiber Substances 0.000 claims description 27
- 239000000835 fiber Substances 0.000 claims description 24
- 210000001124 body fluid Anatomy 0.000 claims description 20
- 239000010839 body fluid Substances 0.000 claims description 20
- 108010015776 Glucose oxidase Proteins 0.000 claims description 16
- 239000004366 Glucose oxidase Substances 0.000 claims description 16
- 239000007850 fluorescent dye Substances 0.000 claims description 16
- 229940116332 glucose oxidase Drugs 0.000 claims description 16
- 235000019420 glucose oxidase Nutrition 0.000 claims description 16
- 230000005284 excitation Effects 0.000 claims description 13
- 239000012528 membrane Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 9
- 238000010791 quenching Methods 0.000 claims description 6
- 230000000171 quenching effect Effects 0.000 claims description 6
- 125000005647 linker group Chemical group 0.000 claims description 3
- JMEAFYJXCJNGCX-UHFFFAOYSA-N butanoic acid;perylene Chemical group CCCC(O)=O.CCCC(O)=O.C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 JMEAFYJXCJNGCX-UHFFFAOYSA-N 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims 2
- 230000001678 irradiating effect Effects 0.000 claims 2
- XHKUTQNVGAHLPK-UHFFFAOYSA-N 2-fluorocyclohexa-2,5-diene-1,4-dione Chemical compound FC1=CC(=O)C=CC1=O XHKUTQNVGAHLPK-UHFFFAOYSA-N 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 28
- 102000004190 Enzymes Human genes 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 24
- 238000000034 method Methods 0.000 description 20
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
- 238000012360 testing method Methods 0.000 description 14
- 239000012530 fluid Substances 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 238000007254 oxidation reaction Methods 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 229940125396 insulin Drugs 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 7
- 238000000576 coating method Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- -1 amino, hydroxyl Chemical group 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000005253 cladding Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthene Chemical compound C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- QTUVCTXXMOZFHS-UHFFFAOYSA-N N-(8-aminooctyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide Chemical compound NCCCCCCCCNC(=O)COC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O QTUVCTXXMOZFHS-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 229940127209 oral hypoglycaemic agent Drugs 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920006327 polystyrene foam Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/7703—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/18—Apparatus specially designed for the use of free, immobilized or carrier-bound enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N2021/6484—Optical fibres
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/7703—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
- G01N2021/7706—Reagent provision
- G01N2021/772—Tip coated light guide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/7769—Measurement method of reaction-produced change in sensor
- G01N2021/7786—Fluorescence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/904—Oxidation - reduction indicators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/207497—Molecular oxygen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/207497—Molecular oxygen
- Y10T436/209163—Dissolved or trace oxygen or oxygen content of a sealed environment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Plasma & Fusion (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Clinical Laboratory Science (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/878,560 US4981779A (en) | 1986-06-26 | 1986-06-26 | Apparatus for monitoring glucose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3781605D1 DE3781605D1 (de) | 1992-10-15 |
| DE3781605T2 true DE3781605T2 (de) | 1993-02-18 |
Family
ID=25372281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8787304539T Expired - Lifetime DE3781605T2 (de) | 1986-06-26 | 1987-05-21 | Geraet zum ueberwachen von glukose. |
Country Status (11)
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8600890A (nl) * | 1986-04-09 | 1987-11-02 | Philips Nv | Halfgeleiderinrichting. |
| US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| SE459099B (sv) * | 1987-12-17 | 1989-06-05 | Gambro Ab | Saett att oevervaka en mikrobiologisk process varvid de uttagna proven blandas med en inhibitor |
| US5055851A (en) * | 1988-05-16 | 1991-10-08 | Trackmobile, Inc. | Vehicle location system |
| JPH0217097A (ja) * | 1988-07-06 | 1990-01-22 | Sanyo Electric Co Ltd | 脱水洗濯機 |
| JPH0280088A (ja) * | 1988-09-19 | 1990-03-20 | Sanyo Electric Co Ltd | 脱水洗濯機 |
| DE3923921A1 (de) * | 1989-07-19 | 1991-01-24 | Biotechnolog Forschung Gmbh | Optischer biosensor |
| US6040194A (en) * | 1989-12-14 | 2000-03-21 | Sensor Technologies, Inc. | Methods and device for detecting and quantifying substances in body fluids |
| US5342789A (en) * | 1989-12-14 | 1994-08-30 | Sensor Technologies, Inc. | Method and device for detecting and quantifying glucose in body fluids |
| US5370114A (en) * | 1992-03-12 | 1994-12-06 | Wong; Jacob Y. | Non-invasive blood chemistry measurement by stimulated infrared relaxation emission |
| US5341805A (en) * | 1993-04-06 | 1994-08-30 | Cedars-Sinai Medical Center | Glucose fluorescence monitor and method |
| US5503559A (en) * | 1993-09-30 | 1996-04-02 | Cedars-Sinai Medical Center | Fiber-optic endodontic apparatus and method |
| US5456252A (en) * | 1993-09-30 | 1995-10-10 | Cedars-Sinai Medical Center | Induced fluorescence spectroscopy blood perfusion and pH monitor and method |
| US5582184A (en) * | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
| US5605152A (en) * | 1994-07-18 | 1997-02-25 | Minimed Inc. | Optical glucose sensor |
| US5879310A (en) * | 1995-09-08 | 1999-03-09 | Integ, Inc. | Body fluid sampler |
| US6614522B1 (en) * | 1995-09-08 | 2003-09-02 | Integ, Inc. | Body fluid sampler |
| US6624882B2 (en) | 1995-09-08 | 2003-09-23 | Integ, Inc. | Methods of sampling body fluid |
| US5879367A (en) | 1995-09-08 | 1999-03-09 | Integ, Inc. | Enhanced interstitial fluid collection |
| EP0812150A4 (en) | 1995-12-28 | 1999-03-10 | Cygnus Therapeutic Systems | CONTINUOUS CONTROL OF A PHYSIOLOGICAL ANALYTE |
| US5954685A (en) * | 1996-05-24 | 1999-09-21 | Cygnus, Inc. | Electrochemical sensor with dual purpose electrode |
| WO1999017095A1 (en) | 1997-09-30 | 1999-04-08 | M-Biotech, Inc. | Biosensor |
| US7066884B2 (en) * | 1998-01-08 | 2006-06-27 | Sontra Medical, Inc. | System, method, and device for non-invasive body fluid sampling and analysis |
| US20060015058A1 (en) * | 1998-01-08 | 2006-01-19 | Kellogg Scott C | Agents and methods for enhancement of transdermal transport |
| US8287483B2 (en) * | 1998-01-08 | 2012-10-16 | Echo Therapeutics, Inc. | Method and apparatus for enhancement of transdermal transport |
| US6922576B2 (en) * | 1998-06-19 | 2005-07-26 | Becton, Dickinson And Company | Micro optical sensor device |
| US6535753B1 (en) * | 1998-08-20 | 2003-03-18 | Microsense International, Llc | Micro-invasive method for painless detection of analytes in extra-cellular space |
| US6844166B1 (en) | 1998-09-11 | 2005-01-18 | Sensor Technologies Inc. | Recombinant reduced valency carbohydrate binding ligands |
| AU1623300A (en) * | 1998-11-13 | 2000-06-05 | Sensor Technologies, Inc. | Monodisperse preparations useful with implanted devices |
| US20040171980A1 (en) | 1998-12-18 | 2004-09-02 | Sontra Medical, Inc. | Method and apparatus for enhancement of transdermal transport |
| US6368563B1 (en) | 1999-03-12 | 2002-04-09 | Integ, Inc. | Collection well for body fluid tester |
| US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
| US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
| US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| ES2315961T3 (es) | 2001-06-08 | 2009-04-01 | F. Hoffmann-La Roche Ag | Dispositivo de extraccion de muestras de fluido corporal. |
| EP1519678A2 (en) * | 2001-10-02 | 2005-04-06 | Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California | Internal biochemical sensing device |
| US20120078075A1 (en) * | 2002-04-04 | 2012-03-29 | Maynard John D | Determination of a measure of a glycation end-product or disease state using tissue fluorescence in combination with one or more other tests |
| WO2006086578A1 (en) * | 2002-10-02 | 2006-08-17 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Internal biochemical sensing device |
| US7226414B2 (en) * | 2002-10-09 | 2007-06-05 | Biotex, Inc. | Method and apparatus for analyte sensing |
| US7166458B2 (en) * | 2003-01-07 | 2007-01-23 | Bio Tex, Inc. | Assay and method for analyte sensing by detecting efficiency of radiation conversion |
| AU2004231988B2 (en) * | 2003-04-16 | 2010-04-15 | Drexel University | Acoustic blood analyzer for assessing blood properties |
| DE10325699B3 (de) * | 2003-06-06 | 2005-02-10 | Roche Diagnostics Gmbh | System zur Analyse einer zu untersuchenden Probe und Verwendung eines solchen Systems |
| US7236812B1 (en) * | 2003-09-02 | 2007-06-26 | Biotex, Inc. | System, device and method for determining the concentration of an analyte |
| US7496392B2 (en) * | 2003-11-26 | 2009-02-24 | Becton, Dickinson And Company | Fiber optic device for sensing analytes |
| US7787923B2 (en) * | 2003-11-26 | 2010-08-31 | Becton, Dickinson And Company | Fiber optic device for sensing analytes and method of making same |
| US8685724B2 (en) | 2004-06-01 | 2014-04-01 | Kwalata Trading Limited | In vitro techniques for use with stem cells |
| US8343074B2 (en) * | 2004-06-30 | 2013-01-01 | Lifescan Scotland Limited | Fluid handling devices |
| WO2006006166A2 (en) | 2004-07-14 | 2006-01-19 | Glusense, Ltd. | Implantable power sources and sensors |
| US20060094944A1 (en) * | 2004-10-28 | 2006-05-04 | Sontra Medical Corporation | System and method for analyte sampling and analysis with error correction |
| US20070207498A1 (en) * | 2005-02-24 | 2007-09-06 | Lifescan, Inc. | Design and construction of dimeric concanavalin a mutants |
| US20060247154A1 (en) * | 2005-02-24 | 2006-11-02 | Lifescan, Inc. | Concanavalin a, methods of expressing, purifying and characterizing concanavalina, and sensors including the same |
| US7432069B2 (en) * | 2005-12-05 | 2008-10-07 | Sontra Medical Corporation | Biocompatible chemically crosslinked hydrogels for glucose sensing |
| TW200734462A (en) | 2006-03-08 | 2007-09-16 | In Motion Invest Ltd | Regulating stem cells |
| US7809441B2 (en) | 2006-05-17 | 2010-10-05 | Cardiac Pacemakers, Inc. | Implantable medical device with chemical sensor and related methods |
| KR101433550B1 (ko) * | 2007-03-07 | 2014-08-27 | 에코 테라퓨틱스, 인크. | 경피 피분석물 모니터링 시스템 및 피분석물 검출 방법 |
| ATE499967T1 (de) * | 2007-04-27 | 2011-03-15 | Echo Therapeutics Inc | Hautpermeationsvorrichtung für analytenmessung oder transdermale arzneiabgabe |
| EP2150586B1 (en) * | 2007-05-22 | 2018-03-14 | Becton, Dickinson and Company | Dyes having ratiometric fluorescence response for detecting metabolites |
| US20080318314A1 (en) * | 2007-06-20 | 2008-12-25 | Valentin Fulga | Production from blood of cells of neural lineage |
| US8702932B2 (en) * | 2007-08-30 | 2014-04-22 | Pepex Biomedical, Inc. | Electrochemical sensor and method for manufacturing |
| US9044178B2 (en) * | 2007-08-30 | 2015-06-02 | Pepex Biomedical, Llc | Electrochemical sensor and method for manufacturing |
| US9023661B2 (en) * | 2007-10-18 | 2015-05-05 | Becton, Dickinson And Company | Visual glucose sensor and methods of use thereof |
| US8320983B2 (en) * | 2007-12-17 | 2012-11-27 | Palo Alto Research Center Incorporated | Controlling transfer of objects affecting optical characteristics |
| US10624577B2 (en) | 2008-04-04 | 2020-04-21 | Hygieia, Inc. | Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
| US9220456B2 (en) | 2008-04-04 | 2015-12-29 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
| US8457901B2 (en) | 2008-04-04 | 2013-06-04 | Hygieia, Inc. | System for optimizing a patient's insulin dosage regimen |
| WO2010056718A2 (en) | 2008-11-11 | 2010-05-20 | Hygieia, Inc. | Apparatus and system for diabetes management |
| US8951377B2 (en) | 2008-11-14 | 2015-02-10 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor module |
| WO2010056878A2 (en) | 2008-11-14 | 2010-05-20 | Pepex Biomedical, Llc | Electrochemical sensor module |
| US8506740B2 (en) | 2008-11-14 | 2013-08-13 | Pepex Biomedical, Llc | Manufacturing electrochemical sensor module |
| US20100160749A1 (en) * | 2008-12-24 | 2010-06-24 | Glusense Ltd. | Implantable optical glucose sensing |
| WO2012162151A2 (en) | 2011-05-20 | 2012-11-29 | Pepex Biomedical, Inc. | Manufacturing electrochemical sensor modules |
| US9037205B2 (en) | 2011-06-30 | 2015-05-19 | Glusense, Ltd | Implantable optical glucose sensing |
| KR101300172B1 (ko) * | 2011-10-05 | 2013-08-26 | (주)지오테크놀러지 | 혈액 분석용 광섬유 센서 장치 |
| EP2925229A4 (en) | 2012-12-03 | 2017-01-25 | Pepex Biomedical, Inc. | Sensor module and method of using a sensor module |
| JP6082273B2 (ja) * | 2013-02-25 | 2017-02-15 | 日本板硝子株式会社 | 蛍光検出装置 |
| CN103335992B (zh) * | 2013-06-21 | 2016-02-10 | 北京交通大学 | 一种荧光式葡萄糖毛细管生物传感器 |
| US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
| US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
| US9097670B1 (en) * | 2014-03-06 | 2015-08-04 | Stardust Materials, LLC | System for measuring dye concentration in liquids |
| US11045124B2 (en) | 2014-06-04 | 2021-06-29 | Pepex Biomedical, Inc. | Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology |
| WO2016059635A1 (en) | 2014-10-13 | 2016-04-21 | Glusense Ltd. | Analyte-sensing device |
| US9892234B2 (en) | 2014-10-27 | 2018-02-13 | Aseko, Inc. | Subcutaneous outpatient management |
| US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
| US10716500B2 (en) | 2015-06-29 | 2020-07-21 | Cardiac Pacemakers, Inc. | Systems and methods for normalization of chemical sensor data based on fluid state changes |
| CA2993275C (en) | 2015-08-20 | 2022-06-21 | Aseko, Inc. | Diabetes management therapy advisor |
| EP3380827B1 (en) * | 2015-11-23 | 2023-11-29 | Revvity Health Sciences, Inc. | Hollow polymer fiber optic system for single analyte and multiplexed analyte detection |
| EP3445872A1 (en) | 2016-04-20 | 2019-02-27 | Glusense Ltd. | Fret-based glucose-detection molecules |
| JP6935806B2 (ja) | 2017-01-19 | 2021-09-15 | Ａｇｃ株式会社 | ガラス板およびその成形方法 |
| GB201706799D0 (en) * | 2017-04-28 | 2017-06-14 | Univ Oslo | Enzyme reactor vessel |
| CN108968976B (zh) | 2017-05-31 | 2022-09-13 | 心脏起搏器股份公司 | 具有化学传感器的植入式医疗设备 |
| WO2019023093A1 (en) | 2017-07-26 | 2019-01-31 | Cardiac Pacemakers, Inc. | SYSTEMS AND METHODS FOR POSTURE DISAMBIGULATION |
| CN109381195B (zh) | 2017-08-10 | 2023-01-10 | 心脏起搏器股份公司 | 包括电解质传感器融合的系统和方法 |
| CN109419515B (zh) | 2017-08-23 | 2023-03-24 | 心脏起搏器股份公司 | 具有分级激活的可植入化学传感器 |
| CN109864746B (zh) | 2017-12-01 | 2023-09-29 | 心脏起搏器股份公司 | 用于医学装置的多模式分析物传感器 |
| CN109864747B (zh) | 2017-12-05 | 2023-08-25 | 心脏起搏器股份公司 | 多模式分析物传感器光电子接口 |
| JP7466170B2 (ja) * | 2018-10-26 | 2024-04-12 | 一般財団法人生産技術研究奨励会 | 尿中物質検出材及びその使用 |
| CN112517093A (zh) * | 2020-11-17 | 2021-03-19 | 四川大学 | 一种Fish唾液自动分样检测盘及其检测方法 |
| US12186076B2 (en) * | 2021-02-09 | 2025-01-07 | Medtronic, Inc. | Optical based glucose sensor |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2833356A1 (de) * | 1978-07-29 | 1980-02-14 | Max Planck Gesellschaft | Verfahren zur optischen messung von stoffkonzentrationen |
| US4344438A (en) * | 1978-08-02 | 1982-08-17 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Optical sensor of plasma constituents |
| JPS584982B2 (ja) * | 1978-10-31 | 1983-01-28 | 松下電器産業株式会社 | 酵素電極 |
| US4317879A (en) * | 1979-05-07 | 1982-03-02 | Airco, Inc. | Glucose analyzer membrane containing immobilized glucose oxidase |
| US4399099A (en) * | 1979-09-20 | 1983-08-16 | Buckles Richard G | Optical fiber apparatus for quantitative analysis |
| US4390621A (en) * | 1980-12-15 | 1983-06-28 | Miles Laboratories, Inc. | Method and device for detecting glucose concentration |
| CH649383A5 (en) * | 1981-01-15 | 1985-05-15 | Max Planck Gesellschaft | Device for measuring concentrations of particles of matter |
| US4330299A (en) * | 1981-03-09 | 1982-05-18 | Evreka, Inc. | Article and method for measuring glucose level in body fluids |
| US4436094A (en) * | 1981-03-09 | 1984-03-13 | Evreka, Inc. | Monitor for continuous in vivo measurement of glucose concentration |
| JPS57208997A (en) * | 1981-06-17 | 1982-12-22 | Fuji Photo Film Co Ltd | Liquid analyzing material for oxidase enzyme reaction system |
| US4431004A (en) * | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| JPS58174832A (ja) * | 1982-03-29 | 1983-10-13 | Nec Corp | 分析装置 |
| US4476870A (en) * | 1982-03-30 | 1984-10-16 | The United States Of America As Represented By The Department Of Health And Human Services | Fiber optic PO.sbsb.2 probe |
| US4460684A (en) * | 1982-08-02 | 1984-07-17 | Miles Laboratories, Inc. | Ascorbate-resistant broad range glucose test composition, test device and method |
| US4548907A (en) * | 1983-09-14 | 1985-10-22 | Allied Corporation | Fluorescent fluid determination method and apparatus |
| US4682895A (en) * | 1985-08-06 | 1987-07-28 | Texas A&M University | Fiber optic probe for quantification of colorimetric reactions |
| US4737343A (en) * | 1986-01-21 | 1988-04-12 | The Regents Of The University Of California | Gas-sensing optrode |
-
1986
- 1986-06-26 US US06/878,560 patent/US4981779A/en not_active Expired - Fee Related
-
1987
- 1987-04-03 CA CA000533792A patent/CA1300395C/en not_active Expired - Lifetime
- 1987-04-08 AU AU71187/87A patent/AU608510B2/en not_active Expired
- 1987-04-09 NZ NZ219926A patent/NZ219926A/en unknown
- 1987-05-21 BR BR8702607A patent/BR8702607A/pt not_active Application Discontinuation
- 1987-05-21 DE DE8787304539T patent/DE3781605T2/de not_active Expired - Lifetime
- 1987-05-21 ES ES198787304539T patent/ES2035053T3/es not_active Expired - Lifetime
- 1987-05-21 EP EP87304539A patent/EP0251475B1/en not_active Expired - Lifetime
- 1987-05-29 JP JP62134743A patent/JPH06104080B2/ja not_active Expired - Lifetime
- 1987-06-05 MX MX006806A patent/MX170234B/es unknown
-
1992
- 1992-09-10 GR GR920401925T patent/GR3005651T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU7118787A (en) | 1988-01-07 |
| EP0251475A1 (en) | 1988-01-07 |
| MX170234B (es) | 1993-08-12 |
| US4981779A (en) | 1991-01-01 |
| GR3005651T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-06-07 |
| EP0251475B1 (en) | 1992-09-09 |
| JPS637799A (ja) | 1988-01-13 |
| AU608510B2 (en) | 1991-04-11 |
| ES2035053T3 (es) | 1993-04-16 |
| DE3781605D1 (de) | 1992-10-15 |
| CA1300395C (en) | 1992-05-12 |
| BR8702607A (pt) | 1988-02-23 |
| JPH06104080B2 (ja) | 1994-12-21 |
| NZ219926A (en) | 1990-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3781605T2 (de) | Geraet zum ueberwachen von glukose. | |
| DE69627097T2 (de) | Blutglucose-Teststreifen mit reduzierter Sensitivität für Hämatokrit | |
| US5001054A (en) | Method for monitoring glucose | |
| DE3752328T2 (de) | Verfahren zur Bestimmung der Konzentration eines Analyts in Vollblut | |
| DE69503792T2 (de) | Analysegerät mit schlangenförmig ausgebildeter teststreifenführung | |
| DE60314042T2 (de) | Vorrichtungen und Methoden zur Bestimmung von Konzentrationen von Analyten | |
| DE69636775T2 (de) | Kombinationstest für den aktuellen glukosespiegel und die mittel- oder langfristige blutzuckerkontrolle | |
| DE69714637T2 (de) | Reagenzteststreifen zum Nachweis von Glukose im Blut | |
| DE69803310T2 (de) | Analytisches gerät mit kapillarreagenzträger | |
| DE69033796T2 (de) | Verfahren und gerät zum nachweis und zur quantifizierung von glukose in körperflüssigkeiten | |
| DE69322968T2 (de) | Verfahren und Vorrichtung zur kontinuierlichen Überwachung eines Anolytpegels | |
| DE69221808T2 (de) | Biosensor und Verfahren zur Messung einer Konzentration eines Substrats in eine Probe | |
| DE60129042T2 (de) | Teststreifen für den gleichzeitigen nachweis mehrerer analyten | |
| DE69903954T2 (de) | Diagnostisches testverfahren für kleine probenvolumina | |
| EP1936362B1 (de) | Testelement mit Referenzierung | |
| DE60007229T2 (de) | Probendetektion zum Initiieren der Zeitmessung eines elektrochemischen Tests | |
| EP2244086B1 (de) | Analyse optischer Daten mit Hilfe von Histogrammen | |
| DE69010143T2 (de) | Testeinrichtung und Verfahren zur Bestimmung von Fructoasminen. | |
| WO2003097864A1 (de) | Verfahren und reagenzsystem mit nicht-regenerierbarem enzym-coenzym-komplex | |
| EP1213579B1 (de) | System zur Analyse von Probeflüssigkeiten beinhaltend eine Lagekontrolleinheit | |
| EP2794909B1 (de) | Verfahren zur bestimmung einer analytkonzentration | |
| AT390803B (de) | Verfahren zur bestimmung der konzentration eines enzymsubstrates und sensor zur durchfuehrung des verfahrens | |
| EP3591378B1 (de) | Verfahren zur bestimmung von lipiden, hämoglobin und bilirubin in körperflüssigkeitsproben | |
| DE3510992C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Kobayashi et al. | Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |